-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Ambrx Biopharma, Inc. quarterly Share-based Payment Arrangement, Expense history and growth rate from Q3 2022 to Q3 2023.
- Ambrx Biopharma, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2023 was $4.82M, a 213% increase year-over-year.
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)